The company is also pleased to announce a formal offer to
Buzzlink.com, a cannabis e-commerce platform for dispensaries and
consumers.
Buzzlink.com
will be financed partially by the issuance of preferred B series
shares.
Metatron approved investors can acquire Series B shares in blocks
of various sizes starting at 1k and recently increased discounts.
The first round investors will receive the highest discount. Series
B shares can be redeemed through the Company, are immune to reverse
splits, and will convert at 1 B share to 50,000 common shares at a
60% discount. There are a limited number of B shares available and
Metatron reserves the right to end offering at any time.
We would also like everyone to to a look at up and coming app
http://
wherewedrink.com a new app that will revolutionize the bar
industry. Metatron does not currently have a financial interest in
the app or company but likes to support the work of great local app
developers. “Get on board early...this one will is a game-changer”
states Joe Riehl.
Details available at
http://metatroninc.com/series-
b/ or
http://www.metatronstock.com.
Metatron’s Apps:
iTunes:
https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play:
https://play.google.com/store/apps/developer?
id=Metatron+Inc
Facebook:
http://www.facebook.com/metatroninc
Twitter:
http://twitter.com/metatroninc
News:
http://metatroninc.com/blog
Forward-Looking Statements:
Any statements made in this press release which are not historical
facts contain certain forward-looking statements, as such term is
defined in the Private Litigation Reform Act of 1995, concerning
potential developments affecting the business, prospects, financial
condition and other aspects of the company to which this release
pertains. These forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause our
actual results of the specific items described in this release, and
the company’s operations generally, to differ materially from what
is projected in such forward-looking statements. Although such
statements are based upon the best judgments of management of the
company as of the date of this release, significant deviations in
magnitude, timing and other factors may result from business risks
and uncertainties including, without limitation, the company’s need
for additional financing, which is not assured and which may result
in dilution of shareholders, the company’s status as a small
company with a limited operating history, dependence on third
parties and the continuing popularity of the iOS operating system,
general market and economic conditions, technical factors, receipt
of revenues, and other factors, many of which are beyond the
control of the company. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance,
or achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of such
statements, and we disclaim any obligation to update information
contained in any forward-looking statement. Metatron does not grow,
sell or distribute any substances that violate United States Law or
the Controlled Substances Act.
